© Reuters. Today’s most important upgrade
By David Kirakosyan
Upgraded Jefferies modern (NASDAQ:) to Buy from Hold and raise price target to $275.00 from $170.00 on an important new pipeline story and catalysts ahead. The new story now is the possibility of a PCV cancer vaccine, RSV Phase III data coming soon, a double-virus vaccine and a triple vaccine by 2023, the analysts said. “.
Atlantic Equity Upgrades Warner Music Corporation (NASDAQ:) to Overweight from Neutral and price target from $34.00 to $41.00, noting that it will rise further if the music industry can deliver sustained price gains.
JPMorgan upgrade Glaukos Corporation (NYSE:) to Neutral from Underweight and lowers price target from $48.00 to $42.00, noting that there appears to be temporary optimism that trends stabilize in fundamental business activity. will support modest growth in 2023 before the iDose launch has been anticipated since the 2015 IPO.
Upgraded MoffettNathanson Verizon Communications (NYSE:) to Market Performance from Worse with a price target of $41.00.
Want to receive this news first? Upgrade InvestPro to cover the market in real time.
